• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致乳房切除术后组织扩张器感染的相关因素。

Contributing variables to post mastectomy tissue expander infection.

机构信息

Division of Plastic Surgery, Department of Surgery, University of Nevada School of Medicine, Las Vegas, Nevada 89102-2227, USA.

出版信息

Breast J. 2012 Jul-Aug;18(4):351-6. doi: 10.1111/j.1524-4741.2012.01253.x. Epub 2012 May 23.

DOI:10.1111/j.1524-4741.2012.01253.x
PMID:22616636
Abstract

Tissue expander breast reconstruction is a common post mastectomy breast procedure performed by plastic surgeons. The purpose of this study was to define the incidence of breast reconstruction prosthetic infection, relate patient characteristics with increased rate of infection, and analyze the influence of postoperative complications to expander/implant infection. A retrospective, single-institution chart review of 195 women with post mastectomy tissue expander/implant reconstructions performed from 2006 through 2008 was conducted. Total periprosthetic infection rate was calculated. Patient factors, operative technique, and noninfectious complications were analyzed and related to increased periprosthetic infection rate. A binary logistic regression model was fitted using periprosthetic infection as the dependent variable and 12 patient characteristics as independent variables, followed by a step-wise model for best fit with a limited number of independent variables. The overall periprosthetic infection rate per patient over the 2 year period was 5.1%. The incidence of periprosthetic infection per reconstructed breast was 3.2%. Odds ratio estimates indicated that the presence of cellulitis increased the odds of periprosthetic infection more than 200 times (p = <0.0001), and inpatient procedures increased the odds 16 times (p = 0.02). Other variables (i.e., age > 65, DM, flap necrosis, smoking, dehiscence, AlloDerm, etc) failed to reach statistical significance (p > 0.05). Postoperative breast cellulitis and inpatient status appear to be significant risk factors for increased periprosthetic infection. No significant increase in periprosthetic infection rate was noted with other variables in this model.

摘要

组织扩张器乳房重建是一种常见的乳房切除术后乳房重建手术,由整形外科医生实施。本研究的目的是定义乳房重建假体感染的发生率,将患者特征与感染率增加相关,并分析术后并发症对扩张器/植入物感染的影响。对 2006 年至 2008 年间接受过乳房切除术后组织扩张器/植入物重建的 195 名女性进行了回顾性、单机构图表回顾。计算了总假体周围感染率。分析了患者因素、手术技术和非传染性并发症,并与假体周围感染率增加相关。使用假体周围感染作为因变量,12 个患者特征作为自变量,拟合二元逻辑回归模型,然后使用有限数量的自变量进行逐步模型以获得最佳拟合。在 2 年期间,每位患者的假体周围感染总发生率为 5.1%。每只重建乳房的假体周围感染发生率为 3.2%。优势比估计表明,蜂窝织炎的存在使假体周围感染的几率增加了 200 多倍(p<0.0001),而住院手术使几率增加了 16 倍(p=0.02)。其他变量(即年龄>65 岁、DM、皮瓣坏死、吸烟、裂开、AlloDerm 等)未达到统计学意义(p>0.05)。术后乳房蜂窝织炎和住院状态似乎是假体周围感染增加的显著危险因素。在该模型中,其他变量并未显著增加假体周围感染率。

相似文献

1
Contributing variables to post mastectomy tissue expander infection.导致乳房切除术后组织扩张器感染的相关因素。
Breast J. 2012 Jul-Aug;18(4):351-6. doi: 10.1111/j.1524-4741.2012.01253.x. Epub 2012 May 23.
2
Long-term reconstructive outcomes after expander-implant breast reconstruction with serious infectious or wound-healing complications.扩张器-植入物乳房重建术后出现严重感染或伤口愈合并发症的长期重建效果。
Ann Plast Surg. 2012 Apr;68(4):369-73. doi: 10.1097/SAP.0b013e31823aee67.
3
Risk factors for mastectomy flap necrosis following immediate tissue expander breast reconstruction.即刻组织扩张器乳房重建术后乳房切除皮瓣坏死的危险因素。
J Plast Surg Hand Surg. 2014 Oct;48(5):322-6. doi: 10.3109/2000656X.2014.884973. Epub 2014 Feb 4.
4
Immediate two-stage tissue expander breast reconstruction compared with one-stage permanent implant breast reconstruction: a multi-institutional comparison of short-term complications.即刻两阶段组织扩张器乳房重建与一期永久性植入物乳房重建的比较:短期并发症的多机构比较
J Plast Surg Hand Surg. 2013 Oct;47(5):344-9. doi: 10.3109/2000656X.2013.767202. Epub 2013 Apr 3.
5
Risk factors for complications of radiation therapy on tissue expander breast reconstructions.组织扩张器乳房重建术后放疗并发症的危险因素。
Breast J. 2012 Jan-Feb;18(1):28-34. doi: 10.1111/j.1524-4741.2011.01182.x. Epub 2011 Nov 20.
6
Outcome analysis of expander/implant versus microsurgical abdominal flap breast reconstruction: a critical study of 254 cases.扩张器/植入物与显微外科腹壁皮瓣乳房重建的疗效分析:对254例病例的批判性研究
Ann Surg Oncol. 2014 Jun;21(6):2074-82. doi: 10.1245/s10434-014-3521-0. Epub 2014 Feb 21.
7
Initial experience with the use of foetal/neonatal bovine acellular dermal collagen matrix (SurgiMend™) for tissue-expander breast reconstruction.胎儿/新生儿牛脱细胞真皮胶原基质(SurgiMend™)在组织扩张器乳房重建中的初步应用经验。
J Plast Reconstr Aesthet Surg. 2013 Sep;66(9):1195-201. doi: 10.1016/j.bjps.2013.05.004. Epub 2013 Jun 13.
8
Complications in tissue expander breast reconstruction: a comparison of AlloDerm, DermaMatrix, and FlexHD acellular inferior pole dermal slings.组织扩张器乳房重建中的并发症:AlloDerm、DermaMatrix和FlexHD脱细胞下极真皮吊带的比较
Ann Plast Surg. 2012 Oct;69(4):347-9. doi: 10.1097/SAP.0b013e31824b3d97.
9
Does the reconstruction method influence development of mastectomy flap complications in nipple-sparing mastectomy?重建方式是否会影响保留乳头的乳房切除术乳房皮瓣并发症的发展?
J Plast Reconstr Aesthet Surg. 2013 Nov;66(11):1543-50. doi: 10.1016/j.bjps.2013.06.032. Epub 2013 Jul 5.
10
The influence of AlloDerm on expander dynamics and complications in the setting of immediate tissue expander/implant reconstruction: a matched-cohort study.在即刻组织扩张器/植入物重建中,同种异体真皮对扩张器动力学及并发症的影响:一项配对队列研究。
Ann Plast Surg. 2008 May;60(5):510-3. doi: 10.1097/SAP.0b013e31816f2836.

引用本文的文献

1
Surgical Management of Breast Capsular Contracture-A Multi-institutional Data Analysis of Risk Factors for Early Complications.乳房包膜挛缩的手术治疗——早期并发症危险因素的多机构数据分析
Aesthetic Plast Surg. 2025 Jan;49(2):516-527. doi: 10.1007/s00266-024-04203-x. Epub 2024 Jun 26.
2
Tissue Expander-Based Breast Reconstruction at a Major Safety-Net Hospital: Managing the Outsized Risk of Infection.在一家大型安全网医院进行的基于组织扩张器的乳房重建:应对感染的巨大风险
Aesthet Surg J Open Forum. 2022 May 2;4:ojac036. doi: 10.1093/asjof/ojac036. eCollection 2022.
3
Strategy for salvaging infected breast implants: lessons from the recovery of seven consecutive patients.
挽救感染乳房植入物的策略:连续七例患者康复的经验教训
Arch Plast Surg. 2021 Mar;48(2):165-174. doi: 10.5999/aps.2020.01578. Epub 2021 Mar 15.
4
Patient determinants as independent risk factors for postoperative complications of breast reconstruction.患者因素作为乳房重建术后并发症的独立危险因素。
Gland Surg. 2017 Aug;6(4):355-367. doi: 10.21037/gs.2017.04.04.
5
Critical Evaluation of Risk Factors of Infection Following 2-Stage Implant-Based Breast Reconstruction.基于植入物的两阶段乳房重建术后感染危险因素的批判性评估
Plast Reconstr Surg Glob Open. 2017 Jul 5;5(7):e1386. doi: 10.1097/GOX.0000000000001386. eCollection 2017 Jul.
6
Reducing infection risk in implant-based breast-reconstruction surgery: challenges and solutions.降低植入式乳房重建手术中的感染风险:挑战与解决方案。
Breast Cancer (Dove Med Press). 2016 Sep 1;8:161-72. doi: 10.2147/BCTT.S97764. eCollection 2016.
7
Improving Antimicrobial Regimens for the Treatment of Breast Tissue Expander-Related Infections.改善用于治疗乳房组织扩张器相关感染的抗菌治疗方案。
Plast Reconstr Surg Glob Open. 2016 May 6;4(5):e704. doi: 10.1097/GOX.0000000000000690. eCollection 2016 May.
8
Individualized Risk of Surgical Complications: An Application of the Breast Reconstruction Risk Assessment Score.手术并发症的个体化风险:乳房重建风险评估评分的应用
Plast Reconstr Surg Glob Open. 2015 Jun 5;3(5):e405. doi: 10.1097/GOX.0000000000000351. eCollection 2015 May.
9
A systematic review of infection rates and associated antibiotic duration in acellular dermal matrix breast reconstruction.脱细胞真皮基质乳房重建中感染率及相关抗生素使用时长的系统评价
Eplasty. 2014 Nov 11;14:e42. eCollection 2014.
10
Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstruction.乳房切除术后即刻假体乳房重建术后引流管防腐的随机试验
Ann Surg Oncol. 2014 Oct;21(10):3240-8. doi: 10.1245/s10434-014-3918-9. Epub 2014 Aug 6.